Pathfinder Cell Therapy (Pathfinder Cell Therapy) COGS-to-Revenue : 0.00 (As of Sep. 2015)

View and export this data going back to . Start your Free Trial

What is Pathfinder Cell Therapy COGS-to-Revenue?

Pathfinder Cell Therapy's Cost of Goods Sold for the three months ended in Sep. 2015 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2015 was $0.00 Mil.

Pathfinder Cell Therapy's COGS to Revenue for the three months ended in Sep. 2015 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Pathfinder Cell Therapy's Gross Margin % for the three months ended in Sep. 2015 was N/A%.

Pathfinder Cell Therapy COGS-to-Revenue Historical Data

The historical data trend for Pathfinder Cell Therapy's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pathfinder Cell Therapy COGS-to-Revenue Chart

Pathfinder Cell Therapy Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

COGS-to-Revenue

Get a 7-Day Free Trial

0.36

0.44

0.69

Pathfinder Cell Therapy Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Pathfinder Cell Therapy COGS-to-Revenue Calculation

Pathfinder Cell Therapy's COGS to Revenue for the fiscal year that ended in Dec. 2014 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Pathfinder Cell Therapy's COGS to Revenue for the quarter that ended in Sep. 2015 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Pathfinder Cell Therapy (OTCPK:PFND) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Pathfinder Cell Therapy's Gross Margin % for the three months ended in Sep. 2015 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Pathfinder Cell Therapy COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pathfinder Cell Therapy's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pathfinder Cell Therapy Inc (OTCPK:PFND) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

12 Bow Street, Cambridge, MA, USA, 02138

Website

http://www.pathfindercelltherapy.com

Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.

Executives

John J Alam	director	130 WAVERLY STREET, CAMBRIDGE MA 02139
John L Brooks	director	100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Headlines

No Headlines